| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to an anticancer drug containing a combination of 1-(3-C-ethinyl-?-D-ribopentifuranosyl)cytosine or its salt, and carboplatin. The invention also refers to the use of this combination for preparing the anticancer agent, a method of treating cancer which comprises administering the combination to the patient, and a method of enhancing the anticancer effect of carboplatin.EFFECT: combination of 1-(3-C-ethinyl-?-D-ribopentifuranosyl)cytosine or its salt, and carboplatin provides the enhanced anticancer effect and the reduced unfavourable effects.8 cl, 3 dwg, 1 tbl, 2 ex |
